Table 2.
Initial values | Values after 8 weeks of treatment | |||||||
---|---|---|---|---|---|---|---|---|
4% Niacinamide (n=10) |
0.05% Retinoic acid (n=10) |
Placebo (n=10) | P value | 4% Niacinamide (n=10) |
0.05% Retinoic acid (n=10) |
Placebo (n=10) | P value | |
| ||||||||
L∗ | 46.5 ± 3.8 | 47.2 ± 3.2 | 47.7 ± 3.8 | 0.16 | 52.7 ± 2.3∗∗ | 50.2 ± 3.1 | 48.4 ± 4.2 | 0.01 |
| ||||||||
a∗ | 11.7 ± 1.8 | 12.1 ± 0.5 | 12.7 ± 0.9 | 0.1 | 11.4 ± 1.2 | 12.3 ± 1.8 | 12.6 ± 2.5 | 0.06 |
| ||||||||
MASI | 15.4 ± 6.7 | 18.5± 13.5 | 9.1± 1.4 | 0.1 | 10.4 ± 5.1 | 12.9 ± 6.4 | 7.1 ± 1.2∗∗ | 0.03 |
| ||||||||
MFI | 70 ± 5 | 74 ± 2 | 68 ± 3 | 0.4 | 50 ± 3 | 53 ± 5 | 64 ± 2∗∗ | <0.01 |
L∗: axis values; a∗: erythema axis values; p values obtained by t test. The groups did not differ in colorimetric, MASI, and MFI values at onset (ANOVA, P >0.05).